Nautilus Biotechnology, Inc.

10-Q Quarter ended 2026-06-30 Jul 28, 2026 8-K Results of operations (earnings release) Jul 28, 2026 8-K Shareholder vote results Jun 18, 2026 10-Q Quarter ended 2026-03-31 Apr 28, 2026 8-K Results of operations (earnings release) Apr 28, 2026 10-K Fiscal year ended 2025-12-31 Feb 26, 2026 8-K Results of operations (earnings release) Feb 26, 2026 8-K Other events Nov 4, 2025 10-Q Quarter ended 2025-09-30 Oct 28, 2025 8-K Results of operations (earnings release) Oct 28, 2025 10-Q Quarter ended 2025-06-30 Jul 31, 2025 8-K Results of operations (earnings release) Jul 31, 2025 8-K Shareholder vote results Jun 23, 2025 8-K Delisting notice or listing-rule failure May 2, 2025 10-Q Quarter ended 2025-03-31 Apr 29, 2025 8-K Results of operations (earnings release) Apr 29, 2025 10-K Fiscal year ended 2024-12-31 Feb 27, 2025 8-K Results of operations (earnings release); Director or officer change Feb 27, 2025 8-K Director or officer change Jan 31, 2025 10-Q Quarter ended 2024-09-30 Oct 29, 2024 8-K Results of operations (earnings release) Oct 29, 2024 10-Q Quarter ended 2024-06-30 Jul 30, 2024 8-K Results of operations (earnings release) Jul 30, 2024 8-K Shareholder vote results Jun 13, 2024 10-Q Quarter ended 2024-03-31 Apr 30, 2024 8-K Results of operations (earnings release) Apr 30, 2024 8-K Entered a material agreement Feb 28, 2024 10-K Fiscal year ended 2023-12-31 Feb 28, 2024 8-K Results of operations (earnings release) Feb 28, 2024 8-K Other events Dec 14, 2023 10-Q Quarter ended 2023-09-30 Oct 31, 2023 8-K Results of operations (earnings release) Oct 31, 2023 10-Q Quarter ended 2023-06-30 Aug 2, 2023 8-K Results of operations (earnings release) Aug 2, 2023 8-K Shareholder vote results Jun 15, 2023 10-Q Quarter ended 2023-03-31 May 2, 2023 8-K Results of operations (earnings release) May 2, 2023 10-K Fiscal year ended 2022-12-31 Feb 23, 2023 8-K Results of operations (earnings release) Feb 23, 2023 10-Q Quarter ended 2022-09-30 Nov 1, 2022